Last kr2.87 SEK
Change Today +0.01 / 0.35%
Volume 71.7K
As of 11:30 AM 08/21/14 All times are local (Market data is delayed by at least 15 minutes).

bioinvent international ab (BINV) Snapshot

Open
kr2.86
Previous Close
kr2.86
Day High
kr2.92
Day Low
kr2.86
52 Week High
11/15/13 - kr4.64
52 Week Low
08/26/13 - kr1.98
Market Cap
323.7M
Average Volume 10 Days
121.0K
EPS TTM
kr-0.13
Shares Outstanding
112.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIOINVENT INTERNATIONAL AB (BINV)

Related News

No related news articles were found.

bioinvent international ab (BINV) Related Businessweek News

No Related Businessweek News Found

bioinvent international ab (BINV) Details

BioInvent International AB (publ), a research-based pharmaceutical company, is engaged in developing and producing antibody-based drugs in the field of oncology with a focus on blood cell cancer. The company’s products under development include BI-505, a drug candidate that is in Phase I clinical trial for the treatment of multiple myeloma. It is also developing BI-1206, an antagonistic antibody aimed at the immunosuppressive target protein Fc gamma receptor IIB, CD32b, which is overexpressed on tumour cells in patients with lymphoma; and ACD-1013, an agonistic immunostimulatory antibody for intratumoural administration of cancer. The Company is conducting research and development of antibodybased drugs in collaborations with external partners, such as Bayer Pharma, Les Laboratoires Servier, Daiichi Sankyo, and Mitsubishi Tanabe Pharma. BioInvent International AB (publ) was founded in 1997 and is based in Lund, Sweden.

Founded in 1997

bioinvent international ab (BINV) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: kr735.0K
Compensation as of Fiscal Year 2013.

bioinvent international ab (BINV) Key Developments

BioInvent Announces Consolidated Earnings Results for the Second Quarter and Six Months Ended June 2014

BioInvent announced consolidated earnings results for the second quarter and six months ended June 2014. For the quarter, the company reported net sales of SEK 32,442,000 against SEK 12,274,000 a year ago. Operating profit was SEK 3,422,000 against operating loss of SEK 10,236,000 a year ago. Profit after financial items was SEK 3,714,000 against loss after financial items of SEK 9,424,000 a year ago. Profit after tax was SEK 3,714,000 against loss after tax of SEK 9,424,000 a year ago. Earnings per diluted share were SEK 0.04 against loss per diluted share of SEK 0.13 a year ago. Cash outflow from current operations was SEK 24,803,000 against SEK 37,360,000 a year ago. For the six months, the company reported net sales of SEK 34,206,000 against SEK 23,912,000 a year ago. Operating loss was SEK 15,664,000 against SEK 24,250,000 a year ago. Loss after tax was SEK 15,219,000 against SEK 23,683,000 a year ago. Loss per diluted share was SEK 0.17 against SEK 0.32 a year ago. Cash outflow from current operations was SEK 47,772,000 against SEK 60,297,000 a year ago.

BioInvent International AB Reports Earnings Results for the First Quarter Ended March 31, 2014

BioInvent International AB reported earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported interim loss after tax was SEK 19 million, or SEK 0.22 per diluted share, from 1 January 2014 to 31 March 2014. This was a decline over loss after tax of SEK 14 million, or SEK 0.19 per diluted share, in first quarter of 2013. Net sales were SEK 1.8 million, as compared with SEK 12 million in first quarter of 2013.

BioInvent International AB, Special/Extraordinary Shareholders Meeting, Mar 19, 2014

BioInvent International AB, Special/Extraordinary Shareholders Meeting, Mar 19, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BINV:SS kr2.87 SEK +0.01

BINV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
arGEN-X BV €8.41 EUR -0.14
Dyax Corp $9.57 USD -0.24
Genmab A/S kr225.50 DKK -3.90
PDL BioPharma Inc $9.85 USD +0.055
XOMA Corp $4.25 USD -0.04
View Industry Companies
 

Industry Analysis

BINV

Industry Average

Valuation BINV Industry Range
No financial data is available for BINV.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOINVENT INTERNATIONAL AB, please visit www.bioinvent.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.